Maria Concetta Pastore Profile
Maria Concetta Pastore

@MC_Pastore

Followers
217
Following
377
Media
10
Statuses
228

MD, Cardiologist🫀, FISC- Researcher and PhD fellow @unisiena - Nucleus Member of #Echo WG and Secretary of #hypertension WG of @SIC_CARDIOLOGIA

Siena, Toscana
Joined June 2020
Don't wanna be here? Send us removal request.
@MC_Pastore
Maria Concetta Pastore
13 days
📣 Updates on the role of #CVimaging to evaluate #mitralregurgitation 🫀, from primary to functional etiologies : read our new review realized on behalf of @SIECVIx Tuscany section‼️ @barleets @eFfe83 @Matte_Cameli @FrancescoBeche4 ➡️ link : https://t.co/PXtej6XPHP
1
12
37
@HFA_President
HFAPresident
26 days
Atrial Functional Mitral Regurgitation (#AFMR): 📍increasingly recognized subtype of #MR 📍caused by #LA remodelling & mitral annular dilation w/o primary valve disease or #LV dysfunction 📍Epidemiology: ~40–65% of FMR, often in the elderly👵🧓, female👩, #HFpEF, #AFib
0
23
69
@Matte_Cameli
Matteo Cameli, MD, PhD
26 days
🔴🔴🔴Tomorrow at 6 pm CEST: EACVI Webinar Cardiac Ultrasound in critically ill patients Proud to be speaker with @EchoSoliman @EACVIPresident @escardio @denisamuraru @unisiena @AouSenese @cardiouni https://t.co/1oMlJiLFxU
0
10
21
@echo_stepbystep
Vladyslav Kavalerchyk 🇺🇦
1 month
Prognostic value of right ventricular longitudinal strain assessed by multimodal imaging in #amyloidosis : systematic review and meta-analysis by @EHJCVIEiC #Research Javier Herrera-Flores et al. https://t.co/6Nh74dMS7g @EACVIPresident @denisamuraru @lpbadano @donal @JGrapsa
Tweet card summary image
academic.oup.com
AbstractAims. Amyloidosis is a progressive and often fatal disease, with right ventricular (RV) involvement emerging as critical determinant of outcomes. T
0
14
20
@HFA_President
HFAPresident
1 month
🔥New Scientific Statement from #HFA & #HFAI: SGLT2 inhibitors for the prevention & treatment of #HeartFailure Key recommendations across the HF spectrum: 📍At risk for HF: ⬇️HF events in patients with #T2DM & #CKD, initiate #SGLT2i 📍Post-AMI: ⬇️HFh alone, consider in
4
90
211
@Ed_Alania
Edgardo Alania
1 month
🧵Family screening in DCM – What cardiologists need to know 🧬🫀 New ESC clinical consensus on managing family members of patients with Dilated Cardiomyopathy (DCM) #Cardiology #CardioEd #Genetics #DCM Tailored screening & genetics are the key 🧩👇
2
64
139
@Matte_Cameli
Matteo Cameli, MD, PhD
2 months
📣📣 Iscriviti alla I edizione del #master in #ecografia cardiaca, polmonare e vascolare @unisiena @AouSenese 💻 Docenti internazionali per un percorso di formazione di 12 mesi in modalità ibrida (online/presenza) 🧑🏻‍⚕️ Tirocinio e sessioni pratiche ➡️ https://t.co/lqLSVY3DUv
0
4
7
@Matte_Cameli
Matteo Cameli, MD, PhD
2 months
📣📣 Torna la IV edizione del #master in #ecocardiografia avanzata nella pratica clinica @unisiena @AouSenese 💻 12 mesi di lezione con docenti internazionali di alto livello per diventare esperto di #echofirst 🧑🏻‍⚕️ Tirocinio e sessioni pratiche ➡️ https://t.co/lqLSVY3DUv
0
5
6
@EACVIPresident
EACVI President
2 months
Strain Echocardiography is probably, toegther with 3D echo, the breakthrough technology of this century 🏆🏆Now mature, see all the clinical applications of this technique in👉: A Clinical Consensus Statement From @ASE360 & @EACVIPresident https://t.co/HHZI2LPBVW… 👏👏Task
4
31
101
@EJHFEiC
EJHF Editor-in-Chief
3 months
Atrial cardiomyopathy: From healthy atria to atrial failure. A clinical consensus statement of the Heart Failure Association of the ESC https://t.co/vi9TOCiMMI #HFA @ESC_Journals @HanCardiomd @AmrAbdin10 @GiuseppeGalati_
1
61
139
@AndrewPAmbrosy
Andrew P. Ambrosy, MD, MPH
3 months
📢 Largest study to date of HFimpEF—out in JACC! 🫀 Among >28K new HFrEF patients, 1 in 3 improved to HFimpEF within 12 months ⚠️ Risk remains: • HF events ↓ • Mortality ↓ • GDMT use declined 🔍 Continuing GDMT is critical. @ankeetbhatt @ATSandhu https://t.co/1l742eArY3
Tweet card summary image
jacc.org
0
13
35
@ankeetbhatt
Ankeet S. Bhatt, MD, MBA
3 months
#HFimpEF is common, but data are limited on #GDMT & outcomes. In @JACCJournals, the largest look at HFimpEF in US to date. 🎯>28K new HFrEF pts, 1 in 3 improved to HFimpEF. 🎯 GDMT ⤵️ after HFimpEF. 🎯 Many pts remained at ⏫ risk. 💡 Tailored trials & #ImpSci strategies needed.
2
32
92
@EJHFEiC
EJHF Editor-in-Chief
4 months
Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of #HFA https://t.co/6dExkeSeKU @ARakisheva #EJHF @HanCardiomd @AmrAbdin10 @GiuseppeGalati_
2
38
67
@EJHFEiC
EJHF Editor-in-Chief
4 months
🗞️Changes in cardiac structure & function are associated with health-related quality of life in heart failure patients with reduced ejection fraction: Results from the #EVALUATE_HF trial @ESC_Journals @GiuseppeGalati_ @AmrAbdin10 @HanCardiomd https://t.co/qoe63nb0Aq
0
13
22
@MC_Pastore
Maria Concetta Pastore
4 months
0
0
0
@MC_Pastore
Maria Concetta Pastore
4 months
⚠️ Practical hints and novel therapies to improve the management of #bloodpressure in frail or #resistant patients 🩺💊⚡️: read our 🆕 review article just published in @JHypertension on behalf of @SIC_CARDIOLOGIA Hypertension WG ! 🫀 📰 link ➡️ https://t.co/yOwPUe6yFW
1
3
8
@CircAHA
Circulation
4 months
A new echocardiographic algorithm provides accurate classification of left ventricular filling pressure, reducing indeterminate cases, particularly in patients with preserved ejection fraction. @SNagueh https://t.co/JPyxVhlXtD
1
53
136
@Matte_Cameli
Matteo Cameli, MD, PhD
4 months
Proud to welcome at @unisiena Prof. @GBisleri for a great international lecture about Imaging-guided mitral valve repair🔥. @UnityHealthTO @CardiouniSiena @UofT @uoftmedicine #StrongerTogether #echofirst @FocardiMarta @DrGEMandoli @MC_Pastore @FlavioDascenzi
0
3
13